Prostate cancer: Localization with three-dimensional proton MR spectroscopic imaging - Clinicopathologic study

Radiology

Volumn 213, Issue 2, 1999, Pages 473-480

  Scheidler, Juergen ^a   Hricak, Hedvig ^a   Vigneron, Daniel B ^a   Yu, Kyle K ^a   Sokolov, Dahlia L ^a   Huang, L Royal ^a   Zaloudek, Charles J ^b   Nelson, Sarah J ^a   Carroll, Peter R ^b   Kurhanewicz, John ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Magnetic resonance (MR), spectroscopy; Magnetic resonance (MR), three dimensional; Prostate, hyperplasia; Prostate, MR; Prostate, neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MALE GENITAL TRACT CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; PROTON NUCLEAR MAGNETIC RESONANCE; RECTUM; THREE DIMENSIONAL IMAGING;

EID: 0032757964     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.213.2.r99nv23473     Document Type: Article

References (38)

1. Silverberg E. Cancer statistics, 1985. CA Cancer J Clin 1985; 35:19-35.
2. Wingo PA, Landio S, Ries LAG. An adjustment to the 1997 estimate for new prostate cancer cases. CA Cancer J Clin 1997; 47:239-242.
3. Waterbor JW, Bueschen AJ. Prostate cancer screening (United States). Cancer Causes Control 1995; 6:267-274.
4. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin 1997; 47:5-27.
5. Hricak H, White S, Vigneron D, et al. Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal - pelvic phased-array coils. Radiology 1994; 193:703-709.
6. Jager GJ, Ruijter ET, van de Kaa CA, et al. Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. AJR 1996; 166:845-852.
7. Presti JC Jr, Hricak H, Narayan PA, Shinohara K, White S, Carroll PR. Local staging of prostatic carcinoma: comparison of transrectal sonography and endorectal MR imaging. AJR 1996; 166:103-108.
8. Quint LE, Van Erp JS, Bland PH, et al. Carcinoma of the prostate: MR images obtained with body coils do not accurately reflect tumor volume. AJR 1991; 156:511-516.
9. Sommer FG, Nghiem HV, Herfkens R, McNeal J, Low RN. Determining the volume of prostatic carcinoma: value of MR imaging with an external-array coil. AJR 1993; 161:81-86.
10. White S, Hricak H, Forstner R, et al. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology 1995; 195:385-390.
11. Evanochoko WT, Ng TC, Glickson JD. Application of in vivo NMR spectroscopy to cancer. Magn Reson Med 1984; 1:508-534.
12. Bruhn H, Frahm J, Gyngell ML, et al. Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experiments in patients with cerebral tumors. Radiology 1989; 172:541-548.
13. 3) spatial resolution. Radiology 1996; 198:795-805.
14. Chen M, Hricak H, Kalbhen CL, et al. Hormonal ablation of prostatic cancer: effects on prostate morphology, tumor detection, and staging by endorectal coil MR imaging. AJR 1996; 166:1157-1163.
15. Vigneron DB, Nelson SJ, Moyher S, Kelley DAC, Kurhanewicz J, Hricak H. An analytical correction of MR images obtained with endorectal or surface coils (abstr). JMRI 1993; 3(P):142.
16. Kurhanewicz J, Vigneron DB, Hricak H, et al. Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging. Radiology 1996; 200:489-496.
17. Star-Lack J, Nelson SJ, Kurhanewicz J, Huang LR, Vigneron DB. Improved water and lipid suppression for 3D PRESS CSI using RF band selective inversion with gradient dephasing (BASING). Magn Reson Med 1997; 38:311-321.
18. Dwyer AJ. Matchmaking and McNemar in the comparison of diagnostic modalities. Radiology 1991; 178:328-330.
19. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148:839-843.
20. Yu KK, Hricak H, Alagappan R, Chernoff DM, Bacchetti P, Zaloudek CJ. Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: multivariate feature analysis. Radiology 1997; 202:697-702.
21. Schiebler ML, Yankaskas BC, Tempany C, et al. MR imaging in adenocarcinoma of the prostate: interobserver variation and efficacy for determining stage C disease. AJR 1992; 158:559-564.
22. Tempany CM, Zhou X, Zerhouni EA, et al. Staging of prostate cancer: results of Radiology Diagnostic Oncology Group project comparison of three MR imaging techniques. Radiology 1994; 192:47-54.
23. Seltzer SE, Getty DJ, Tempany CM, et al. Staging prostate cancer with MR imaging: a combined radiologist-computer system. Radiology 1997; 202:219-226.
24. Outwater EK, Petersen RO, Siegelman ES, Gomella LG, Chernesky CE, Mitchell DG. Prostate carcinoma: assessment of diagnostic criteria for capsular penetration on endorectal coil MR images. Radiology 1994; 193:333-339.
25. Harris RD, Schned AR, Heaney JA. Staging of prostate cancer with endorectal MR imaging: lessons from a learning curve. RadioGraphics 1995; 15:813-832.
26. Schnall MD, Imai Y, Tomaszewski J, Pollack HM, Lenkinski RE, Kressel HY. Prostate cancer: local staging with endorectal surface coil MR imaging. Radiology 1991; 178:797-802.
27. Tempany CM, Rahmouni AD, Epstein JI, Walsh PC, Zerhouni EA. Invasion of the neurovascular bundle by prostate cancer: evaluation with MR imaging. Radiology 1991; 181:107-112.
28. Ragde H, Blasko JC, Grimm PD, et al. Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma. Cancer 1997; 80:442-453.
29. Stokes SH, Real JD, Adams PW, Clements JC, Wuertzer S, Kan W. Transperineal ultrasound-guided radioactive seed implantation for organ-confined carcinoma of the prostate. Int J Radiat Oncol Biol Phys 1997; 37:337-341.
30. Stone NN, Stock RG. Brachytherapy for prostate cancer: real-time three-dimensional interactive seed implantation. Tech Urol 1995; 1:72-80.
31. Amin Z, Lees WR, Bown SG. Technical note: interstitial laser photocoagulation for the treatment of prostatic cancer. Br J Radiol 1993; 66:1044-1047.
32. Lee F, Bahn DK, McHugh TA, Onik GM, Lee FT Jr. US-guided percutaneous cryoablation of prostate cancer. Radiology 1994; 192:769-776.
33. Onik GM, Cohen JK, Reyes GD, Rubinsky B, Chang Z, Baust J. Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate. Cancer 1993; 72:1291-1299.
34. Chodak GW, Thisted RA, Gerber GS, et al. Results of conservative management of clinically localized prostate cancer. N Engl J Med 1994; 330:242-248.
35. Lee F, Torp-Pedersen S, Littrup PJ, et al. Hypoechoic lesions of the prostate: clinical relevance of tumor size, digital rectal examination, and prostate-specific antigen. Radiology 1989; 170:29-32.
36. Olsson C. Prostatic cancer. Kidney Int 1993; 43:955-965.
37. Kurhanewicz J, Vigneron DB, Nelson SJ, et al. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. Urology 1995; 45: 459-466.
38. Vigneron DB, Males R, Noworolski S, et al. 3D MRSI of prostate cancer: correlation with histologic grade (abstr). In: Proceedings of the Sixth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 1998; 487.